Lumos Pharma (LUMO) Stock Chart & Stock Price History → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free LUMO Stock Alerts $3.02 +0.02 (+0.67%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lumos Pharma Stock Price Performance5 Day Performance+2.03%1 Month Performance+13.96%3 Month Performance-0.33%6 Month Performance-25.06%Year-To-Date Performance-5.03%1 Year Performance-14.93% Receive LUMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read LUMO Stock Chart for Wednesday, May, 8, 2024 LUMO Chart by TradingView Lumos Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.00$3.02+0.67%$3.07$2.9226,477 shs$24.52 million05/06/2024$2.96$3.00+1.35%$3.05$2.9142,163 shs$24.35 million05/03/2024$3.04$2.96-2.63%$3.05$2.9069,636 shs$24.04 million05/02/2024$3.02$3.04+0.66%$3.06$2.98125,196 shs$24.69 million05/01/2024$2.87$3.02+5.23%$3.07$2.73270,583 shs$24.51 million04/30/2024$2.89$2.87-0.69%$2.90$2.7019,517 shs$23.30 million Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$2.77$2.89+4.33%$2.92$2.7713,699 shs$23.47 million04/26/2024$2.76$2.83+2.36%$2.83$2.74688 shs$22.94 million04/25/2024$2.82$2.76-2.13%$2.81$2.711,569 shs$22.41 million04/24/2024$2.80$2.82+0.71%$2.93$2.7246,348 shs$22.90 million04/23/2024$2.68$2.80+4.48%$2.85$2.7017,078 shs$22.74 million04/22/2024$2.59$2.68+3.47%$2.69$2.604,650 shs$21.75 million04/19/2024$2.62$2.59-1.15%$2.83$2.5312,311 shs$21.03 million04/18/2024$2.46$2.62+6.50%$2.76$2.4112,386 shs$21.27 million04/17/2024$2.52$2.46-2.38%$2.53$2.4114,403 shs$19.97 million04/16/2024$2.45$2.52+2.86%$2.69$2.4618,763 shs$20.44 million04/15/2024$2.64$2.45-7.20%$2.57$2.4128,356 shs$19.87 million04/12/2024$2.71$2.55-5.90%$2.73$2.4115,352 shs$20.68 million04/11/2024$2.69$2.71+0.74%$2.90$2.6923,100 shs$21.98 million04/10/2024$2.69$2.69$2.69$2.69582 shs$21.82 million04/09/2024$2.65$2.69+1.51%$2.77$2.654,262 shs$21.82 million04/08/2024$2.74$2.65-3.28%$2.84$2.659,114 shs$21.49 million04/05/2024$2.78$2.77-0.36%$2.81$2.732,550 shs$22.47 million04/04/2024$2.76$2.78+0.72%$2.84$2.6012,271 shs$22.55 million04/03/2024$2.84$2.76-2.82%$2.85$2.766,882 shs$22.38 million04/02/2024$2.86$2.84-0.70%$2.84$2.753,462 shs$23.03 million04/01/2024$2.82$2.86+1.42%$2.90$2.804,523 shs$23.20 million03/29/2024$2.82$2.82$2.94$2.828,854 shs$22.87 million03/28/2024$2.82$2.82$2.94$2.828,854 shs$22.87 million03/27/2024$2.86$2.82-1.40%$2.95$2.816,500 shs$22.87 million03/26/2024$2.79$2.86+2.51%$2.90$2.7718,110 shs$23.20 million03/25/2024$2.78$2.79+0.36%$2.85$2.756,857 shs$22.63 million03/22/2024$2.90$2.78-4.14%$2.86$2.7112,721 shs$22.55 million03/21/2024$2.89$2.90+0.35%$2.94$2.7520,544 shs$23.52 million03/20/2024$2.73$2.89+5.86%$2.93$2.6021,508 shs$23.44 million03/19/2024$2.66$2.73+2.63%$2.81$2.6517,662 shs$22.14 million03/18/2024$2.70$2.66-1.48%$2.84$2.6413,181 shs$21.57 million03/15/2024$2.66$2.70+1.50%$2.80$2.6533,735 shs$21.90 million03/14/2024$2.97$2.66-10.44%$3.03$2.5156,451 shs$21.57 million03/13/2024$3.02$2.97-1.66%$3.04$2.976,657 shs$24.08 millionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company03/12/2024$3.05$3.02-0.98%$3.08$3.0235,901 shs$24.49 million03/11/2024$3.04$3.05+0.33%$3.05$2.9737,379 shs$24.74 million03/08/2024$3.03$3.04+0.33%$3.10$2.97133,300 shs$24.05 million03/07/2024$3.02$3.03+0.33%$3.05$2.985,915 shs$23.97 million03/06/2024$3.05$3.02-0.98%$3.05$2.9710,927 shs$23.89 million03/05/2024$3.01$3.05+1.33%$3.12$3.0070,149 shs$24.13 million03/04/2024$3.00$3.01+0.33%$3.05$3.008,833 shs$23.81 million03/01/2024$3.05$3.00-1.64%$3.05$2.9311,377 shs$23.73 million02/29/2024$3.05$3.05$3.05$2.917,158 shs$24.13 million02/28/2024$3.04$3.05+0.33%$3.05$2.9520,045 shs$24.13 million02/27/2024$2.99$3.04+1.84%$3.05$3.0330,681 shs$24.05 million02/26/2024$3.00$2.99-0.50%$3.05$2.8253,869 shs$23.61 million02/23/2024$3.02$2.94-2.65%$3.03$2.897,999 shs$23.26 million02/22/2024$2.96$3.02+2.20%$3.03$2.917,194 shs$23.89 million02/21/2024$3.04$2.96-2.80%$3.00$2.965,581 shs$23.37 million02/20/2024$2.96$3.04+2.70%$3.05$2.9218,597 shs$24.05 million02/19/2024$2.96$2.96$3.06$2.9120,000 shs$23.41 million02/16/2024$3.05$2.96-2.95%$3.06$2.9120,028 shs$23.41 million02/15/2024$3.05$3.05$3.12$3.0123,008 shs$24.13 million02/14/2024$3.04$3.05+0.33%$3.10$2.989,921 shs$24.13 million02/13/2024$3.15$3.04-3.49%$3.23$2.997,376 shs$24.05 million02/12/2024$2.99$3.15+5.35%$3.30$2.9546,129 shs$24.92 million02/09/2024$3.03$2.99-1.32%$3.05$2.9420,327 shs$23.65 million02/08/2024$3.05$3.03-0.66%$3.09$2.9510,655 shs$23.97 million02/07/2024$3.01$3.05+1.33%$3.09$3.0020,861 shs$24.13 million Related Companies: Biora Therapeutics Stock Chart CytoMed Therapeutics Stock Chart Cumberland Pharmaceuticals Stock Chart Lisata Therapeutics Stock Chart Oncternal Therapeutics Stock Chart Bullfrog AI Stock Chart Lipocine Stock Chart Benitec Biopharma Stock Chart TherapeuticsMD Stock Chart Flora Growth Stock Chart Receive LUMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUMO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.